EUVIMEDEUVIMED entdecken
Open Access

Microbiome Therapeutic Lactiplantibacillus plantarum PMC105 for Systemic Carbapenem-Resistant Enterobacteriaceae Infections: Oral and Inhalation Efficacy In Vivo

Faezeh Sarafraz, Hoonhee Seo, Hanieh Tajdozian, Ali Atashi, Youjin Yoon, Sukyung Kim, Ho-Yeon Song

Journal of Microbiology and Biotechnology · 29.12.2025 · 35

DOI: 10.4014/jmb.2508.08009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 29.12.2025. Verfasst von Faezeh Sarafraz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan-si, Chungnam 31151, Republic of Korea. Hauptthemen laut MEDLINE: Carbapenem-Resistant Enterobacteriaceae, Probiotics, Enterobacteriaceae Infections, Lactiplantibacillus plantarum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea, Korea Institute for Advancement of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbapenem-Resistant EnterobacteriaceaeProbioticsEnterobacteriaceae InfectionsLactiplantibacillus plantarumAnimalsMiceAdministration, OralDisease Models, AnimalKlebsiella pneumoniaeAnti-Bacterial AgentsGastrointestinal MicrobiomeAdministration, InhalationFemaleDysbiosisMicrobial Sensitivity TestsKlebsiella InfectionsHumansCarbapenems

Stichwörter der Autor:innen

Carbapenem-resistant EnterobacteriaceaeLactiplantibacillus plantarumcarbapenem-resistant Klebsiella pneumoniaemouse modelprobiotics

Substanzen

Anti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan-si, Chungnam 31151, Republic of Korea.
  • K-Microbiome Institute, Soonchunhyang University, Asan-si, Chungnam 31538, Republic of Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea
  • Korea Institute for Advancement of Technology
  • Ministry of Trade, Industry and Energy
  • Soonchunhyang University

Zitieren

APA

Sarafraz, F., Seo, H., Tajdozian, H., Atashi, A., Yoon, Y., Kim, S., & Song, H. Y. (2025). Microbiome Therapeutic Lactiplantibacillus plantarum PMC105 for Systemic Carbapenem-Resistant Enterobacteriaceae Infections: Oral and Inhalation Efficacy In Vivo. Journal of Microbiology and Biotechnology, 35. https://doi.org/10.4014/jmb.2508.08009

Vancouver

Sarafraz F, Seo H, Tajdozian H, Atashi A, Yoon Y, Kim S, et al. Microbiome Therapeutic Lactiplantibacillus plantarum PMC105 for Systemic Carbapenem-Resistant Enterobacteriaceae Infections: Oral and Inhalation Efficacy In Vivo. Journal of Microbiology and Biotechnology. 2025;35. doi:10.4014/jmb.2508.08009

BibTeX
@article{Sarafraz2025,
  author = {Sarafraz, Faezeh and Seo, Hoonhee and Tajdozian, Hanieh and Atashi, Ali and Yoon, Youjin and Kim, Sukyung and Song, Ho-Yeon},
  title = {Microbiome Therapeutic Lactiplantibacillus plantarum PMC105 for Systemic Carbapenem-Resistant Enterobacteriaceae Infections: Oral and Inhalation Efficacy In Vivo},
  journal = {Journal of Microbiology and Biotechnology},
  year = {2025},
  volume = {35},
  doi = {10.4014/jmb.2508.08009}
}
Kostenlos starten →